Format

Send to

Choose Destination
Cancer Inform. 2014 Dec 8;13:179-86. doi: 10.4137/CIN.S19222. eCollection 2014.

Computational Construction of Antibody-Drug Conjugates Using Surface Lysines as the Antibody Conjugation Site and a Non-cleavable Linker.

Author information

1
School of Electrical and Computer Engineering, National Technical University of Athens, Athens, Greece. ; Bioinformatics and Medical Informatics Team, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
2
Bioinformatics and Medical Informatics Team, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
3
School of Electrical and Computer Engineering, National Technical University of Athens, Athens, Greece.

Abstract

Antibody-drug conjugates (ADCs) constitute a category of anticancer targeted therapy that has gathered great interest during the last few years because of their potential to kill cancer cells while causing significantly fewer side effects than traditional chemotherapy. In this paper, a process of computational construction of ADCs is described, using the surface lysines of an antibody and a non-covalent linker molecule, as well as a cytotoxic substance, as files in Protein Data Bank format. Also, aspects related to the function, properties, and development of ADCs are discussed.

KEYWORDS:

antibody–drug conjugate; cancer; targeted therapy

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center